Pair Name | Tenacissoside G, Fluorouracil | ||
Phytochemical Name | Tenacissoside G (PubChem CID: 44561398 ) | ||
Anticancer drug Name | Fluorouracil (PubChem CID: 3385 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Tenacissoside G, Fluorouracil | |||
Disease Info | [ICD-11: 2B91] | Colorectal cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Up-regulation | Cleavage | CASP3 | hsa836 |
Up-regulation | Cleavage | CASP8 | hsa841 | |
Up-regulation | Cleavage | CASP9 | hsa842 | |
Down-regulation | Expression | CCND1 | hsa595 | |
Down-regulation | Expression | CDK2 | hsa1017 | |
Down-regulation | Expression | CDK4 | hsa1019 | |
Down-regulation | Expression | CDK6 | hsa1021 | |
Up-regulation | Expression | CDKN1A | hsa1026 | |
Up-regulation | Phosphorylation | TP53 | hsa7157 | |
In Vitro Model | RKO | Colon carcinoma | Homo sapiens (Human) | CVCL_0504 |
In Vivo Model | RKO cells at a density of 3×10⁶/ml were suspended in cold PBS, and a volume of 100 μl cell suspension was administrated subcutaneously in the right flank of each mouse. | |||
Result | TG potentiated 5-FU's inhibitory activity to human colorectal cancer through arresting cell cycle progression and inducing p53-mediated apoptosis, which may present a novel strategy in CRC therapies and contribute to the optimizing clinical application of 5-FU. |
No. | Title | Href |
---|---|---|
1 | Tenacissoside G synergistically potentiates inhibitory effects of 5-fluorouracil to human colorectal cancer. Phytomedicine. 2021 Jun;86:153553. doi: 10.1016/j.phymed.2021.153553. | Click |